Neuland Laboratories Limited (NEULANDLAB.BO)
INR 14649.65
(-0.98%)
INR 14649.65
(-0.98%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 5.31 Billion INR | 85.98% |
| 2022 | 2.16 Billion INR | 170.6% |
| 2021 | 800.52 Million INR | -18.15% |
| 2020 | 978.09 Million INR | 86.21% |
| 2019 | 525.25 Million INR | 209.04% |
| 2018 | 169.96 Million INR | 16.41% |
| 2017 | 146 Million INR | -81.04% |
| 2016 | 769.93 Million INR | 22.79% |
| 2015 | 627.04 Million INR | 44.53% |
| 2014 | 433.85 Million INR | -15.82% |
| 2013 | 515.4 Million INR | 19.16% |
| 2012 | 432.54 Million INR | 30.88% |
| 2011 | 330.48 Million INR | 2.43% |
| 2010 | 322.64 Million INR | 155.39% |
| 2009 | 126.33 Million INR | -43.12% |
| 2008 | 222.08 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 1.07 Billion INR | 18.38% |
| 2023 Q2 | 1.22 Billion INR | 47.57% |
| 2023 Q1 | 833.34 Million INR | -21.67% |
| 2023 FY | 4.02 Billion INR | 85.98% |
| 2023 Q4 | 904.54 Million INR | -14.76% |
| 2023 Q3 | 1.06 Billion INR | -13.71% |
| 2022 Q3 | 407.46 Million INR | -27.4% |
| 2022 Q2 | 561.24 Million INR | 255.1% |
| 2022 FY | 2.16 Billion INR | 170.6% |
| 2022 Q1 | 158.05 Million INR | -40.16% |
| 2022 Q4 | 1.06 Billion INR | 161.09% |
| 2021 FY | 800.52 Million INR | -18.15% |
| 2021 Q4 | 264.14 Million INR | 34.37% |
| 2021 Q3 | 196.57 Million INR | -36.28% |
| 2021 Q2 | 308.51 Million INR | 122.59% |
| 2021 Q1 | 138.6 Million INR | -3.56% |
| 2020 Q1 | 256.79 Million INR | 36.25% |
| 2020 Q3 | 363.87 Million INR | 13.01% |
| 2020 Q4 | 143.71 Million INR | -60.5% |
| 2020 Q2 | 321.97 Million INR | 25.39% |
| 2020 FY | 978.09 Million INR | 86.21% |
| 2019 Q3 | 213.64 Million INR | 23.94% |
| 2019 FY | 525.25 Million INR | 209.04% |
| 2019 Q2 | 172.37 Million INR | 48.25% |
| 2019 Q4 | 188.47 Million INR | -11.78% |
| 2019 Q1 | 116.27 Million INR | 63.18% |
| 2018 FY | 169.96 Million INR | 16.41% |
| 2018 Q1 | 45.89 Million INR | 0.0% |
| 2018 Q2 | 95.22 Million INR | 107.49% |
| 2018 Q3 | 90.12 Million INR | -5.35% |
| 2018 Q4 | 71.25 Million INR | -20.94% |
| 2017 FY | 146 Million INR | -81.04% |
| 2016 Q3 | 150.12 Million INR | -27.37% |
| 2016 FY | 769.93 Million INR | 22.79% |
| 2016 Q2 | 206.69 Million INR | 1.14% |
| 2016 Q4 | 323.16 Million INR | 115.27% |
| 2016 Q1 | 204.35 Million INR | 0.0% |
| 2015 FY | 627.04 Million INR | 44.53% |
| 2014 FY | 433.85 Million INR | -15.82% |
| 2013 FY | 515.4 Million INR | 19.16% |
| 2012 FY | 432.54 Million INR | 30.88% |
| 2011 FY | 330.48 Million INR | 2.43% |
| 2010 FY | 322.64 Million INR | 155.39% |
| 2009 FY | 126.33 Million INR | -43.12% |
| 2008 FY | 222.08 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Ajanta Pharma Limited | 19.67 Billion INR | 72.973% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -1062.313% |
| Sigachi Industries Limited | 1.47 Billion INR | -260.819% |
| Bal Pharma Limited | 233.9 Million INR | -2173.573% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -20.304% |
| Medico Remedies Limited | 100.3 Million INR | -5202.185% |
| Lasa Supergenerics Limited | -458 Million INR | 1261.143% |
| Venus Remedies Limited | 534.65 Million INR | -894.685% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 229.235% |
| Alpa Laboratories Limited | 184.49 Million INR | -2782.482% |
| Nectar Lifesciences Limited | 923.8 Million INR | -475.672% |
| Shilpa Medicare Limited | 1.36 Billion INR | -289.241% |
| Aarti Drugs Limited | 7.14 Billion INR | 25.608% |
| Lupin Limited | 28.04 Billion INR | 81.037% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 87.399% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 87.663% |
| Windlas Biotech Limited | 1.29 Billion INR | -309.434% |
| Suven Life Sciences Limited | -1.22 Billion INR | 533.839% |
| Eris Lifesciences Limited | 5.18 Billion INR | -2.632% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 62.766% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 238.028% |
| Ipca Laboratories Limited | 7.98 Billion INR | 33.362% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -332.014% |
| Achyut Healthcare Limited | 4.43 Million INR | -119730.825% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 94.901% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| RPG Life Sciences Limited | 2.29 Billion INR | -131.998% |
| Mankind Pharma Limited | 21.51 Billion INR | 75.285% |
| Laurus Labs Limited | 3.94 Billion INR | -34.683% |
| Piramal Pharma Limited | 4.55 Billion INR | -16.704% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -2033.629% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 79.009% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 7.642% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 18.213% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -748.857% |
| Wanbury Limited | 569.71 Million INR | -833.464% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -15.419% |
| Wockhardt Limited | -670 Million INR | 893.745% |
| Themis Medicare Limited | 392.58 Million INR | -1254.621% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -946.601% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -2.488% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 40.773% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 92.148% |
| Divi's Laboratories Limited | 33.08 Billion INR | 83.924% |
| NATCO Pharma Limited | 25.96 Billion INR | 79.516% |
| Gufic Biosciences Limited | 1.32 Billion INR | -299.884% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -233.047% |
| Ind-Swift Limited | 1.22 Billion INR | -333.789% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -90.886% |
| FDC Limited | 2.98 Billion INR | -78.088% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 3599.735% |
| Granules India Limited | 6.81 Billion INR | 21.984% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 19.46 Billion INR | 72.674% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -209.641% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -58542.275% |
| Brooks Laboratories Limited | 14.44 Million INR | -36728.892% |
| Megasoft Limited | -121.1 Million INR | 4491.343% |
| ZIM Laboratories Limited | 253.82 Million INR | -1995.148% |
| Strides Pharma Science Limited | 5.22 Billion INR | -1.766% |
| Morepen Laboratories Limited | 4.17 Billion INR | -27.415% |
| Hikal Limited | 32.11 Million INR | -16462.105% |
| Indoco Remedies Limited | 1.29 Billion INR | -311.442% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -70.009% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -2456.161% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -19268.097% |
| Hester Biosciences Limited | 364.81 Million INR | -1357.77% |